Rockefeller Capital Management
SANA icon

Rockefeller Capital Management’s Sana Biotechnology SANA Stock Holding History

Rockefeller Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.6K Sell
11,065
-2,700
-20% -$8.7K ﹤0.01% 3481
2026
Q1 		$39.6K Buy
13,765
+4,177
+44% +$16.5K ﹤0.01% 3396
2025
Q4 		$39K Buy
9,588
+4,088
+74% +$18.3K ﹤0.01% 3189
2025
Q3 		$19.5K Buy
+5,500
New +$19.9K ﹤0.01% 3368

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Rockefeller Capital Management's SANA Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Sana Biotechnology (SANA) stake by 20% in Q2 2026, selling an estimated $8.7K and leaving 11,065 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3481.

Rockefeller Capital Management first reported a position in SANA in Q3 2025 and has held it in 4 quarters since. The position peaked at $39.6K in Q1 2026. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Rockefeller Capital Management held 11,065 shares of Sana Biotechnology worth $38.6K as of Q2 2026.
  • Rockefeller Capital Management sold 2,700 Sana Biotechnology shares in Q2 2026, an estimated $8.7K.
  • Sana Biotechnology made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3481 holding.
  • Rockefeller Capital Management first reported a position in Sana Biotechnology in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's Sana Biotechnology position peaked at $39.6K in Q1 2026.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.